Guishuai Lv

3.2k total citations · 3 hit papers
18 papers, 2.0k citations indexed

About

Guishuai Lv is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guishuai Lv has authored 18 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Guishuai Lv's work include MicroRNA in disease regulation (4 papers), interferon and immune responses (3 papers) and Cancer Cells and Metastasis (3 papers). Guishuai Lv is often cited by papers focused on MicroRNA in disease regulation (4 papers), interferon and immune responses (3 papers) and Cancer Cells and Metastasis (3 papers). Guishuai Lv collaborates with scholars based in China, South Korea and United States. Guishuai Lv's co-authors include Hongyang Wang, Hongwei Lv, Wen Yang, Tian Fang, Changzheng Wang, Qin Han, Linna Guo, Liang Tang, Shanhua Tang and Le‐Xing Yu and has published in prestigious journals such as Nature, Nature Communications and Cell Metabolism.

In The Last Decade

Guishuai Lv

18 papers receiving 2.0k citations

Hit Papers

Tumor-derived exosomal mi... 2018 2026 2020 2023 2018 2020 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
    2018 779 citations Tian Fang, Hongwei Lv et al. Nature Communications profile →
  2. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
    2020 260 citations Daqian Xu, Zheng Wang et al. Nature profile →
  3. TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer
    2024 62 citations Hongwei Lv, Guishuai Lv et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guishuai Lv China 15 1.3k 1.0k 330 305 180 18 2.0k
Tian Fang China 17 1.1k 0.8× 708 0.7× 257 0.8× 157 0.5× 122 0.7× 32 1.6k
Xiangsheng Zuo United States 23 1.3k 1.0× 602 0.6× 650 2.0× 274 0.9× 159 0.9× 41 2.2k
Lin Lin China 28 1.4k 1.1× 1.2k 1.1× 323 1.0× 193 0.6× 177 1.0× 100 2.4k
Liankang Sun China 31 1.4k 1.1× 996 1.0× 606 1.8× 200 0.7× 193 1.1× 55 2.2k
Chao Gu China 26 1.2k 0.9× 631 0.6× 234 0.7× 348 1.1× 180 1.0× 82 1.9k
Ninel Azoitei Germany 15 1.4k 1.1× 919 0.9× 803 2.4× 292 1.0× 202 1.1× 28 2.3k
Kuo‐Tai Hua Taiwan 30 1.7k 1.3× 716 0.7× 492 1.5× 293 1.0× 179 1.0× 62 2.3k
Yufeng Wang China 28 2.0k 1.5× 1.7k 1.6× 337 1.0× 167 0.5× 214 1.2× 42 2.5k
Shu‐Wing Ng United States 22 1.1k 0.8× 698 0.7× 250 0.8× 378 1.2× 169 0.9× 41 2.2k
Yi Luo China 24 895 0.7× 499 0.5× 273 0.8× 174 0.6× 214 1.2× 75 1.7k

Countries citing papers authored by Guishuai Lv

Since Specialization
Citations

This map shows the geographic impact of Guishuai Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guishuai Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guishuai Lv more than expected).

Fields of papers citing papers by Guishuai Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guishuai Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guishuai Lv. The network helps show where Guishuai Lv may publish in the future.

Co-authorship network of co-authors of Guishuai Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Guishuai Lv. A scholar is included among the top collaborators of Guishuai Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guishuai Lv. Guishuai Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lv, Hongwei, Liang Wang, Guishuai Lv, et al.. (2025). Traditional medicine Bazi Bushen potentiates immunosurveillance of senescent liver cancer cells via cGAS-STING signaling activation in macrophages. Cancer Letters. 627. 217544–217544. 1 indexed citations
2.
Yan, Bing, Qiang Lü, Tianming Gao, et al.. (2025). CD146 regulates the stemness and chemoresistance of hepatocellular carcinoma via JAG2-NOTCH signaling. Cell Death and Disease. 16(1). 150–150. 4 indexed citations
3.
Lv, Hongwei, Guishuai Lv, Wei Xiang, et al.. (2024). TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer. Nature Communications. 15(1). 6–6. 62 indexed citations breakdown →
4.
Lv, Hongwei, Xiaoyan Sun, Yue Ma, et al.. (2023). Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Science Advances. 9(49). eadi2465–eadi2465. 86 indexed citations
5.
Lv, Guishuai, Wei Xiang, Yue Ma, et al.. (2023). Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials. Cancer Letters. 571. 216348–216348. 31 indexed citations
6.
Han, Qin, et al.. (2020). ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway. Hepatobiliary & pancreatic diseases international. 20(3). 251–261. 41 indexed citations
7.
Xu, Daqian, Zheng Wang, Yan Xia, et al.. (2020). The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. Nature. 580(7804). 530–535. 260 indexed citations breakdown →
8.
Lv, Hongwei, Guishuai Lv, Guo‐Qing Jiang, et al.. (2020). NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion. Cell Metabolism. 33(1). 110–127.e5. 179 indexed citations
9.
Xu, Daqian, Xinjian Li, Fei Shao, et al.. (2019). The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62. Science Advances. 5(4). eaav4570–eaav4570. 64 indexed citations
10.
Fang, Tian, Hongwei Lv, Guishuai Lv, et al.. (2018). Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nature Communications. 9(1). 191–191. 779 indexed citations breakdown →
11.
Lv, Hongwei, Guishuai Lv, Qin Han, Wen Yang, & Hongyang Wang. (2018). Noncoding RNAs in liver cancer stem cells: The big impact of little things. Cancer Letters. 418. 51–63. 40 indexed citations
12.
Lv, Hongwei, Changzheng Wang, Tian Fang, et al.. (2018). Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2. npj Precision Oncology. 2(1). 1–1. 123 indexed citations
13.
Chen, Xin, Ling Yan, Yanping Wei, et al.. (2018). Dual regulation of HMGB1 by combined JNK1/2–ATF2 axis with miR‐200 family in nonalcoholic steatohepatitis in mice. The FASEB Journal. 32(5). 2722–2734. 28 indexed citations
14.
Lv, Guishuai, Yexiong Tan, Hongwei Lv, et al.. (2017). MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition. Science China Life Sciences. 60(11). 1203–1213. 9 indexed citations
15.
Wang, Changzheng, Hongwei Lv, Wen Yang, et al.. (2017). SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts. Cancer Letters. 398. 1–11. 36 indexed citations
16.
Lv, Guishuai, et al.. (2017). The Gut Microbiota, Tumorigenesis, and Liver Diseases. Engineering. 3(1). 110–114. 20 indexed citations
17.
Wu, Fuquan, Tian Fang, Le‐Xing Yu, et al.. (2016). ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α. Journal of Hepatology. 65(2). 314–324. 179 indexed citations
18.
Fang, Tian, Hongwei Lv, Fuquan Wu, et al.. (2016). Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation. Cancer Letters. 384. 50–59. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tian Fang Breakdown of academic impact, for papers by Xiangsheng Zuo Breakdown of academic impact, for papers by Lin Lin Breakdown of academic impact, for papers by Liankang Sun Breakdown of academic impact, for papers by Chao Gu Breakdown of academic impact, for papers by Ninel Azoitei Breakdown of academic impact, for papers by Kuo‐Tai Hua Breakdown of academic impact, for papers by Yufeng Wang Breakdown of academic impact, for papers by Shu‐Wing Ng Breakdown of academic impact, for papers by Yi Luo
Rankless by CCL
2026